NCT00251485 - A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions

Colorectal Cancer

Interventions

DRUG

Cetuximab

Cycle 1: 400 mg/m2 (given as a 2-hour infusion) on Day 1, then 250 mg/m2, Day 8 (given as a 1-hour infusion) subsequent cycles:250 mg/m2, Day 1 and Day 8 (given as a 1-hour infusion)

Trial Locations (1)

77042

Veeda Oncology, Houston